University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract

Not Applicable

Withdrawn

Conditions: Papilloma
Upper Aerodigestive Tract Lesions
Neoplasms, Oropharyngeal
Carcinoma, Squamous Cell
Oropharyngeal Cancer
Neoplasms, Hypopharyngeal
Head and Neck Neoplasms
UADT Neoplasms
Hypopharyngeal Cancer

First Posted Date: 2010-08-04

Last Posted Date: 2014-08-19

Lead Sponsor: University of California, San Francisco

Registration Number: NCT01175499

The Effect of General Anesthesia on the Risk for Arrhythmia

Completed

Conditions: Arrhythmia

First Posted Date: 2010-08-03

Last Posted Date: 2013-10-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 125

Registration Number: NCT01174251

Locations: 🇺🇸
UCSF Medical Center (Moffitt/Long, Mt. Zion), San Francisco, California, United States

Effects of Levetiracetam (Keppra) on Alcohol Consumption

Not Applicable

Completed

Conditions: Alcohol Abuse
Drug Abuse

Interventions: Drug: Levetiracetam (Keppra)
Drug: Placebo

First Posted Date: 2010-07-23

Last Posted Date: 2020-08-28

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 46

Registration Number: NCT01168687

Locations: 🇺🇸
Children's Hospital Oakland Research Institute- CRC, Berkeley, California, United States

Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease

Completed

Conditions: Gastroesophageal Reflux
Dental Erosion

First Posted Date: 2010-07-22

Last Posted Date: 2010-07-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 79

Registration Number: NCT01167543

Locations: 🇺🇸
University of California, San Francisco Dental School, San Francisco, California, United States

Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

Phase 2

Terminated

Conditions: Persistent Corneal Epithelial Defects

Interventions: Drug: Vehicle only
Drug: Nexagon

First Posted Date: 2010-07-19

Last Posted Date: 2015-05-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2

Registration Number: NCT01165450

Computer-Based Balance Training for People With Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Behavioral: gait and balance training program

First Posted Date: 2010-07-14

Last Posted Date: 2012-04-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 62

Registration Number: NCT01162226

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Maintaining Nonsmoking

Phase 3

Completed

Conditions: Nicotine Dependence

Interventions: Drug: Varenicline
Behavioral: Initial Individual counseling
Behavioral: Check-ins with medical staff
Behavioral: Extended Individual Counseling - Health Model
Behavioral: Extended Individual Counseling - Relapse Prevention Model

First Posted Date: 2010-07-14

Last Posted Date: 2020-11-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 216

Registration Number: NCT01162239

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma

Phase 1

Completed

Conditions: Pancreatic Neoplasms
Pancreatic Cancer
Adenocarcinoma

Interventions: Drug: nab-paclitaxel, gemcitabine, capecitabine

First Posted Date: 2010-07-13

Last Posted Date: 2012-10-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 15

Registration Number: NCT01161186

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

The Use of Leukapheresis to Support HIV Pathogenesis Studies

Recruiting

Conditions: HIV

Interventions: Procedure: Leukapheresis

First Posted Date: 2010-07-13

Last Posted Date: 2023-05-30

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 100

Registration Number: NCT01161199

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

A Study of Neural Circuit Responses to Catechol-O-methyl Transferase (COMT) Inhibitors

Not Applicable

Completed

Conditions: Impulsive Behavior

Interventions: Other: Placebo
Drug: Tolcapone

First Posted Date: 2010-07-08

Last Posted Date: 2020-11-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 26

Registration Number: NCT01158950

Locations: 🇺🇸
UCSF: Ernest Gallo Clinic and Research Center, Emeryville, California, United States
🇺🇸
University of California, Berkeley, Berkeley, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy